Activation of this pathway in neurons via insulin growth factor 1 is protective against huntingtin-induced toxicity in experimental Huntington’s disease models; however, contrasting observations were made in the peripheral immune cell compartment of Huntington’s disease patients [173]. This evidence concerns the gene HTT and Huntington disease.